Australia fines Roche for marketing violations

Roche was fined $400,000 for violations of Medicines Australia's code of conduct, including an offer to fund a nurse's salary if a clinic increased use of Pegasys, its hepatitis C drug. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.